Form 4: Quest Diagnostics Director Timothy L. Main Reports Acquisition of Restricted Share Units
SEC Form 4
Director Timothy L. Main reported acquiring 1,482 restricted share units of Quest Diagnostics on May 16, 2024.
Summary
- On May 16, 2024, Timothy L. Main, a director of Quest Diagnostics Inc., acquired 1,482 shares of common stock through an award of restricted share units.
- The transaction was reported on a Form 4 filing with the SEC.
- Following the transaction, Main directly owns 25,094 shares of Quest Diagnostics.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of a transaction. The acquisition of shares by a director is generally viewed as a positive, but it's not a major event.
Positives
- The acquisition of restricted share units by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's prospects.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/16/2024 | Date of transaction: Acquisition of restricted share units. |
| 05/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.